/ /

  • linkedin
  • Increase Font
  • Sharebar

    Connect with ARVO colleagues during AAO

    With the annual meeting of the American Academy of Ophthalmology (AAO) next month in New Orleans within sight, plan to attend the ARVO/AAO Combined Symposium, titled “Recent Advances in Management of Diabetic Retinopathy.”


    With the paradigm shift in treatments demonstrated in recent trials, clinicians can now implement these therapies and increase the ability to improve visual acuity in patients with diabetic retinopathy.

    A panel of experts, moderated by Jennifer Irene Lim, MD, FARVO, will focus on potential roles of new diagnostic technology, improved medical management, and the use of anti-vascular endothelial growth factor (VEGF) agents for the various stages of diabetic retinopathy.

    Here’s who is speaking:

    • Lloyd P. Aiello, MD, PhD, FARVO

    • Abdhish R. Bhavsar, MD

    • Amani Fawzi, MD

    • Jeffrey G. Gross, MD

    • Julia A. Haller, MD, FARVO

    • Judy E. Kim, MD

    • Jennifer K. Sun MD, MPH

    • John A. Wells, III, MD


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results